5-Arylisoxazolyl-3-carboxaldehydes were condensed with N-aryl acetoaceta¬mide and ammonium acetate in methanol to give N3,N5-diaryl-4-(5-arylisoxazol-3-yl)-1,4-dihydropyridine-3,5-dicarboxamides. All compounds were screened for their antitubercular activity against Mycobacterium tuberculosis (H37Rv). The results for new synthesized compounds showed a moderate activity in comparison to rifampicin.
. (2008). Synthesis and Antitubercular Activity of N3,N5-Diaryl-4-(5-arylisoxazol-3-yl)-1,4-dihydropyridine-. (e31904). Journal of Sciences, Islamic Republic of Iran, 19(4), e31904
MLA
. "Synthesis and Antitubercular Activity of N3,N5-Diaryl-4-(5-arylisoxazol-3-yl)-1,4-dihydropyridine-" .e31904 , Journal of Sciences, Islamic Republic of Iran, 19, 4, 2008, e31904.
HARVARD
. (2008). 'Synthesis and Antitubercular Activity of N3,N5-Diaryl-4-(5-arylisoxazol-3-yl)-1,4-dihydropyridine-', Journal of Sciences, Islamic Republic of Iran, 19(4), e31904.
CHICAGO
, "Synthesis and Antitubercular Activity of N3,N5-Diaryl-4-(5-arylisoxazol-3-yl)-1,4-dihydropyridine-," Journal of Sciences, Islamic Republic of Iran, 19 4 (2008): e31904,
VANCOUVER
. Synthesis and Antitubercular Activity of N3,N5-Diaryl-4-(5-arylisoxazol-3-yl)-1,4-dihydropyridine-. J. Sci. I. R. I.. 2008;19(4):e31904.